Table 2 MLH1 mutations detected in gastric cancer cases compared with controls.

-93 G>A

0.736

GG

36 (15.3%)

42(17.5%)

1.00

GA

111 (47.0%)

114(47.5%)

AA

89 (37.7%)

84(35.0%)

GA+AA

200 (84.7%)

198(82.5%)

1.18 (0.72-1.92)

0.510

A allele

61.2%

58.8%

0.435

-28A>G

1.000^c

AA

232 (98.3%)

236 (98.3%)

1.00

AG

4 (1.7%)

4 (1.7%)

1.02 (0.25-4.14)

0.978

G allele

0.85%

0.83%

1.000 ^c

649C>T (R217C)

0.120 ^c

CC

231 (97.9%)

239 (99.6%)

1.00

CT

5(2.1%)

1 (0.4%)

5.25 (0.61-45.45)

0.132

T allele

1.1%

0.2%

0.121 ^c

655A>G (I219V)

0.257

AA

229 (97.0%)

228 (95.0%)

1.00

AG

7 (3.0%)

12 (5.0%)

0.58 (0.22-1.50)

0.262

G allele

1.5%

2.5%

0.262

1151T>A (V384D)

1.000 ^c

TT

232 (98.3%)

236 (98.3%)

TA

4 (1.7%)

4 (1.7%)

1.02 (0.25-4.15)

0.976

A allele

0.85%

0.83%

1.000 ^c

2101C>A (Q701K)

0.120

CC

228 (96.6%)

237 (98.8%)

1.00

CA

8 (3.4%)

3 (1.3%)

2.77 (0.73 -10.57)

0.136

A allele

1.7%

0.6%

0.122